Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 1 of Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging

Autor: Oliveira, Carol, Amstutz, Florian, Vuong, Diem, Bogowicz, Marta, Hüllner, Martin, Foerster, Robert, Basler, Lucas, Schröder, Christina, Eboulet, Eric I., Pless, Miklos, Thierstein, Sandra, Peters, Solange, Hillinger, Sven, Tanadini-Lang, Stephanie, Guckenberger, Matthias

Additional file 1. Supplement A1: 18-Month Results. Supplement A2: Training Cohort Ethics Board Amendment Documents. Supplement A3: PET-Specific Information from the Training Cohort and Validation Cohort. Supplement A4: Venn Diagrams of the Robustnes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a71d1b6e4ac757af0c26c3891fa9ae9f

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial.

Autor: Rothschild SI; Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, Basel, Switzerland., Zippelius A; Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, Basel, Switzerland., Eboulet EI; SAKK Coordinating Center, Bern, Switzerland., Savic Prince S; Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Betticher D; Department of Oncology, HFR Fribourg-Hôpital fribourgeois, Fribourg, Switzerland., Bettini A; Department of Oncology, HFR Fribourg-Hôpital fribourgeois, Fribourg, Switzerland., Früh M; Department of Oncology/Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland.; Department of Oncology, Inselspital Bern, Bern, Switzerland., Joerger M; Department of Oncology/Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland., Lardinois D; Division of Thoracic Surgery, University Hospital Basel, Basel, Switzerland., Gelpke H; Department of Thoracic and Visceral Surgery, Cantonal Hospital Winterthur, Winterthur, Switzerland., Mauti LA; Department of Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland., Britschgi C; Department of Medical Oncology and Hematology, Comprehensive Cancer Center Zurich, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Weder W; Department of Thoracic Surgery, University Hospital of Zurich, Zurich, Switzerland., Peters S; Department of Oncology, University Hospital Lausanne CHUV, Lausanne, Switzerland., Mark M; Divison of Oncology/Hematology, Cantonal Hospital Graubünden, Chur, Switzerland., Cathomas R; Divison of Oncology/Hematology, Cantonal Hospital Graubünden, Chur, Switzerland., Ochsenbein AF; Department of Oncology, Inselspital Bern, Bern, Switzerland., Janthur WD; Department of Oncology/Hematology, Cantonal Hospital Aarau, Aarau, Switzerland., Waibel C; Department of Oncology, Cantonal Hospital Baden, Baden, Switzerland., Mach N; Department of Oncology, University Hospital Geneva, Geneva, Switzerland., Froesch P; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Buess M; Division of Medical Oncology, St Claraspital, Basel, Switzerland., Bohanes P; Centre de Chimiothérapie Anti-Cancéreuse, Lausanne, Switzerland., Godar G; SAKK Coordinating Center, Bern, Switzerland., Rusterholz C; SAKK Coordinating Center, Bern, Switzerland., Gonzalez M; Department of Thoracic Surgery, University Hospital Lausanne CHUV, Lausanne, Switzerland., Pless M; Department of Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Sep 10; Vol. 39 (26), pp. 2872-2880. Date of Electronic Publication: 2021 Jul 12.